0 XP   0   0   0

Acorda Therapeutics Inc










Financial Health of Acorda




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings  


Richest
#312 / 673

Total Sales
#272 / 673

Making Money
#165 / 673

Working Efficiently
#51 / 673

Acorda Therapeutics Inc
Buy, Hold or Sell?

Should you buy, hold or sell Acorda?

I guess you are interested in Acorda Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Acorda

Let's start. I'm going to help you getting a better view of Acorda Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Acorda Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Acorda Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Acorda Therapeutics Inc. The closing price on 2022-11-25 was $0.61 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Acorda Therapeutics Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Acorda Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Acorda earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -41.3% means that $-0.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acorda Therapeutics Inc:

  • The MRQ is -41.3%. The company is making a huge loss. -2
  • The TTM is -89.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-41.3%TTM-89.0%+47.7%
TTM-89.0%YOY-122.9%+33.8%
TTM-89.0%5Y-77.9%-11.1%
5Y-77.9%10Y-34.4%-43.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.3%0.4%-41.7%
TTM-89.0%0.3%-89.3%
YOY-122.9%0.2%-123.1%
5Y-77.9%-0.7%-77.2%
10Y-34.4%-0.1%-34.3%
1.1.2. Return on Assets

Shows how efficient Acorda is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • -3.5% Return on Assets means that Acorda generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Acorda Therapeutics Inc:

  • The MRQ is -3.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.5%TTM-6.3%+2.8%
TTM-6.3%YOY-7.3%+1.0%
TTM-6.3%5Y-4.8%-1.5%
5Y-4.8%10Y-1.8%-3.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%0.1%-3.6%
TTM-6.3%0.1%-6.4%
YOY-7.3%-0.1%-7.2%
5Y-4.8%-0.2%-4.6%
10Y-1.8%0.1%-1.9%
1.1.3. Return on Equity

Shows how efficient Acorda is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • -18.3% Return on Equity means Acorda generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Acorda Therapeutics Inc:

  • The MRQ is -18.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-26.1%+7.8%
TTM-26.1%YOY-19.9%-6.2%
TTM-26.1%5Y-15.2%-10.9%
5Y-15.2%10Y-6.6%-8.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.3%0.6%-18.9%
TTM-26.1%0.4%-26.5%
YOY-19.9%0.4%-20.3%
5Y-15.2%-0.3%-14.9%
10Y-6.6%0.1%-6.7%

1.2. Operating Efficiency of Acorda Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Acorda is operating .

  • Measures how much profit Acorda makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -28.5% means the company generated $-0.29  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acorda Therapeutics Inc:

  • The MRQ is -28.5%. The company is operating very inefficient. -2
  • The TTM is -39.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-28.5%TTM-39.0%+10.5%
TTM-39.0%YOY-106.9%+67.9%
TTM-39.0%5Y-63.4%+24.4%
5Y-63.4%10Y-29.0%-34.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.5%2.5%-31.0%
TTM-39.0%1.6%-40.6%
YOY-106.9%2.7%-109.6%
5Y-63.4%1.8%-65.2%
10Y-29.0%0.8%-29.8%
1.2.2. Operating Ratio

Measures how efficient Acorda is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.15 means that the operating costs are $1.15 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Acorda Therapeutics Inc:

  • The MRQ is 1.149. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.546. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.149TTM1.546-0.397
TTM1.546YOY1.711-0.165
TTM1.5465Y1.441+0.105
5Y1.44110Y1.179+0.263
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1491.473-0.324
TTM1.5461.456+0.090
YOY1.7111.398+0.313
5Y1.4411.374+0.067
10Y1.1791.191-0.012

1.3. Liquidity of Acorda Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Acorda is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.28 means the company has $1.28 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Acorda Therapeutics Inc:

  • The MRQ is 1.277. The company is just able to pay all its short-term debts.
  • The TTM is 3.701. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.277TTM3.701-2.424
TTM3.701YOY1.532+2.169
TTM3.7015Y2.901+0.801
5Y2.90110Y3.426-0.525
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2771.880-0.603
TTM3.7011.901+1.800
YOY1.5322.112-0.580
5Y2.9012.182+0.719
10Y3.4261.891+1.535
1.3.2. Quick Ratio

Measures if Acorda is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.89 means the company can pay off $0.89 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acorda Therapeutics Inc:

  • The MRQ is 0.892. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.602. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.892TTM2.602-1.710
TTM2.602YOY0.822+1.780
TTM2.6025Y2.766-0.165
5Y2.76610Y3.941-1.175
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8920.733+0.159
TTM2.6020.796+1.806
YOY0.8220.808+0.014
5Y2.7660.834+1.932
10Y3.9410.821+3.120

1.4. Solvency of Acorda Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Acorda assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Acorda to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.81 means that Acorda assets are financed with 80.7% credit (debt) and the remaining percentage (100% - 80.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Acorda Therapeutics Inc:

  • The MRQ is 0.807. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.740. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.807TTM0.740+0.068
TTM0.740YOY0.633+0.107
TTM0.7405Y0.615+0.124
5Y0.61510Y0.532+0.084
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8070.437+0.370
TTM0.7400.424+0.316
YOY0.6330.398+0.235
5Y0.6150.398+0.217
10Y0.5320.401+0.131
1.4.2. Debt to Equity Ratio

Measures if Acorda is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 419.1% means that company has $4.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Acorda Therapeutics Inc:

  • The MRQ is 4.191. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.038. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.191TTM3.038+1.153
TTM3.038YOY1.726+1.312
TTM3.0385Y1.760+1.278
5Y1.76010Y1.270+0.490
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1910.652+3.539
TTM3.0380.675+2.363
YOY1.7260.623+1.103
5Y1.7600.684+1.076
10Y1.2700.697+0.573

2. Market Valuation of Acorda Therapeutics Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Acorda generates.

  • Above 15 is considered overpriced but always compare Acorda to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -0.53 means the investor is paying $-0.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acorda Therapeutics Inc:

  • The EOD is -1.072. Company is losing money. -2
  • The MRQ is -0.527. Company is losing money. -2
  • The TTM is -1.300. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.072MRQ-0.527-0.545
MRQ-0.527TTM-1.300+0.773
TTM-1.300YOY-3.240+1.940
TTM-1.3005Y-4.342+3.042
5Y-4.34210Y88.129-92.471
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-1.072-0.124-0.948
MRQ-0.527-0.437-0.090
TTM-1.300-0.102-1.198
YOY-3.24015.340-18.580
5Y-4.3427.916-12.258
10Y88.1297.700+80.429
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Acorda.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Acorda Therapeutics Inc:

  • The MRQ is -0.222. Very Bad. -2
  • The TTM is 0.314. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.222TTM0.314-0.537
TTM0.314YOY3.361-3.047
TTM0.3145Y2.549-2.234
5Y2.54910Y18.586-16.037
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2220.012-0.234
TTM0.3140.010+0.304
YOY3.3610.004+3.357
5Y2.5490.010+2.539
10Y18.5860.021+18.565

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Acorda is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.10 means the investor is paying $0.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Acorda Therapeutics Inc:

  • The EOD is 0.196. Very good. +2
  • The MRQ is 0.096. Very good. +2
  • The TTM is 0.230. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.196MRQ0.096+0.100
MRQ0.096TTM0.230-0.133
TTM0.230YOY0.484-0.254
TTM0.2305Y0.449-0.219
5Y0.44910Y0.892-0.443
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.1961.415-1.219
MRQ0.0961.586-1.490
TTM0.2302.019-1.789
YOY0.4842.230-1.746
5Y0.4491.895-1.446
10Y0.8921.505-0.613
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Acorda Therapeutics Inc.

3.1. Institutions holding Acorda Therapeutics Inc

Institutions are holding 26.899% of the shares of Acorda Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Davidson Kempner Capital Management LP9.84320.021239566823956680
2022-06-30Canyon Capital Advisors LLC4.90580.0441119398854495783.9647
2022-06-30Renaissance Technologies Corp3.70330.000590131819410027.4456
2022-06-30Acadian Asset Management LLC2.80490.001668267067667011277.8333
2022-06-30Millennium Management LLC1.27990.0001311509270588661.2448
2022-06-30Vanguard Group Inc0.64940158061-183484-53.7218
2022-06-30Virtu Financial LLC0.59710.00581453181453180
2022-06-30HN Saltoro Capital, LP0.44710.012210882793979632.9405
2022-06-30Bridgeway Capital Management, LLC0.41790.0011101706-142384-58.3326
2022-06-30Wells Fargo & Co0.30680746712479649.7163
2022-06-30Prudential Financial Inc0.2473060200602000
2022-06-30Geode Capital Management, LLC0.19204672100
2022-06-30Susquehanna International Group, LLP0.1885045880458800
2022-06-30HRT FINANCIAL LLC0.16160.000239319393190
2022-06-30State Street Corporation0.1303164800
2022-06-30UBS Group AG0.117902869825883919.4671
2022-06-30TWO SIGMA SECURITIES, LLC0.11380.000527692276920
2022-06-30Tower Research Capital LLC0.11190.000327234266554603.6269
2022-09-30United Asset Strategies Inc0.11130.00122710000
2022-06-30Northern Trust Corp0.1073026118-510-1.9153
Total 26.4370.08866434346+4245327+66.0%

3.2. Funds holding Acorda Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31Vanguard Extended Market Index Investor0.65050.00021583194110035.0626
2022-06-30Bridgeway Ultra-Small Company Market0.41790.024910170600
2022-10-31Vanguard Strategic Small-Cap Equity Inv0.15640.0033806000
2022-09-30Fidelity® Extended Market Index0.084302052000
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.06170.00011501300
2022-06-30BlackRock Extended Mkt Composite0.05670.000113810138100
2022-09-30BlackRock Extended Equity Market K0.0501012193-112-0.9102
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.04970.0001121061621.3563
2022-09-30Fidelity® Total Market Index0.042701039700
2022-10-31iShares Core S&P Total US Stock Mkt ETF0.03210782400
2022-09-30NT Ext Equity Mkt Idx Fd - L0.03120.0001758400
2022-09-30Northern Trust Extended Eq Market Idx0.03120.0001758400
2022-09-30Fidelity® Series Total Market Index0.03080750600
2022-09-30Fidelity® NASDAQ Composite Index®0.02510611000
2022-09-30State St US Extended Mkt Indx NL Cl C0.02150.0001523800
2022-09-30SSgA U.S. Extended Market Index Class I0.02150.0001523800
2022-09-30BlackRock U.S. Equity Market F0.014703584110.3079
2022-06-30Gabelli Equity Trust0.00710173600
2022-09-30SSgA U.S. Total Market Index Strategy0.00670162250.3092
2022-09-30Spartan Total Market Index Pool E0.0050121200
Total 1.79690.0288437362+54976+12.6%

3.3. Insider Transactions

Insiders are holding 0.685% of the shares of Acorda Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-03-17Ron CohenSELL22891.7
2019-12-02Jane WasmanSELL22271.6117420
2019-12-02Ron CohenSELL46991.6607287
2019-02-22Lauren M SabellaSELL76113.185092
2019-01-30Scopia Capital Management LpSELL700016.01
2019-01-25Scopia Capital Management LpSELL1100116.02
2019-01-23Scopia Capital Management LpSELL9784316.01
2019-01-17Scopia Capital Management LpSELL10000016.86
2019-01-15Scopia Capital Management LpSELL170016.6
2019-01-10Scopia Capital Management LpSELL16249117.18
2019-01-07Scopia Capital Management LpSELL7500016.56
2019-01-03Scopia Capital Management LpSELL2361615.74
2018-12-28Scopia Capital Management LpSELL5289114.99
2018-12-28Scopia Capital Management LpSELL5289114.99
2018-12-26Scopia Capital Management LpSELL5000014.66
2018-12-20Scopia Capital Management LpSELL4500014.25
2018-12-18Scopia Capital Management LpSELL12185316.78
2018-12-14Scopia Capital Management LpSELL6185716.21
2018-12-12Scopia Capital Management LpSELL30000016.3
2018-12-10Scopia Capital Management LpSELL3500019.07

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Acorda Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.499-0.911+83%-1.141+129%-1.241+149%-0.170-66%
Book Value Growth---0.160-0.221+38%-0.178+11%-0.135-16%-0.021-87%
Book Value Per Share--3.1134.544-31%8.209-62%13.775-77%17.836-83%
Book Value Per Share Growth---0.160-0.221+38%-0.138-14%-0.134-17%-0.020-88%
Current Ratio--1.2773.701-66%1.532-17%2.901-56%3.426-63%
Debt To Asset Ratio--0.8070.740+9%0.633+28%0.615+31%0.532+52%
Debt To Equity Ratio--4.1913.038+38%1.726+143%1.760+138%1.270+230%
Dividend Per Share----0%-0%-0%0.028-100%
Eps---0.569-1.085+91%-1.710+200%-1.438+153%-0.604+6%
Eps Growth--2.3700.512+362%0.178+1230%0.833+185%-3.710+257%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.413-0.890+115%-1.229+197%-0.779+88%-0.344-17%
Operating Margin---0.285-0.390+37%-1.069+275%-0.634+122%-0.290+2%
Operating Ratio--1.1491.546-26%1.711-33%1.441-20%1.179-3%
Pb Ratio0.196+51%0.0960.230-58%0.484-80%0.449-79%0.892-89%
Pe Ratio-1.072-103%-0.527-1.300+147%-3.240+515%-4.342+724%88.129-101%
Peg Ratio---0.2220.314-171%3.361-107%2.549-109%18.586-101%
Price Per Share0.610+51%0.3001.193-75%3.733-92%7.839-96%19.040-98%
Price To Total Gains Ratio-1.223-103%-0.601-1.728+187%-3.961+559%-2.375+295%3.743-116%
Profit Growth--236.95751.245+362%17.546+1250%81.576+190%-372.034+257%
Quick Ratio--0.8922.602-66%0.822+9%2.766-68%3.941-77%
Return On Assets---0.035-0.063+80%-0.073+108%-0.048+37%-0.018-50%
Return On Equity---0.183-0.261+42%-0.199+9%-0.152-17%-0.066-64%
Revenue Growth--0.073-0.036+149%-0.158+315%-0.142+293%-0.059+180%
Total Gains Per Share---0.499-0.911+83%-1.141+129%-1.241+149%-0.142-72%
Total Gains Per Share Growth--2.2650.594+281%0.052+4262%0.099+2193%-1.918+185%
Usd Book Value--75766000.000110589750.000-31%199797500.000-62%337169950.000-78%435028121.951-83%
Usd Book Value Change Per Share---0.499-0.911+83%-1.141+129%-1.241+149%-0.170-66%
Usd Book Value Per Share--3.1134.544-31%8.209-62%13.775-77%17.836-83%
Usd Dividend Per Share----0%-0%-0%0.028-100%
Usd Eps---0.569-1.085+91%-1.710+200%-1.438+153%-0.604+6%
Usd Price Per Share0.610+51%0.3001.193-75%3.733-92%7.839-96%19.040-98%
Usd Profit---13854000.000-26406250.000+91%-41608500.000+200%-34947650.000+152%-14671512.195+6%
Usd Revenue--33511000.00031015750.000+8%32565750.000+3%61068650.000-45%86475536.585-61%
Usd Total Gains Per Share---0.499-0.911+83%-1.141+129%-1.241+149%-0.142-72%
 EOD+2 -3MRQTTM+23 -9YOY+23 -95Y+19 -1310Y+13 -21

4.2. Fundamental Score

Let's check the fundamental score of Acorda Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.072
Price to Book Ratio (EOD)Between0-10.196
Net Profit Margin (MRQ)Greater than0-0.413
Operating Margin (MRQ)Greater than0-0.285
Quick Ratio (MRQ)Greater than10.892
Current Ratio (MRQ)Greater than11.277
Debt to Asset Ratio (MRQ)Less than10.807
Debt to Equity Ratio (MRQ)Less than14.191
Return on Equity (MRQ)Greater than0.15-0.183
Return on Assets (MRQ)Greater than0.05-0.035
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Acorda Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.800
Ma 20Greater thanMa 500.683
Ma 50Greater thanMa 1000.521
Ma 100Greater thanMa 2000.480
OpenGreater thanClose0.600
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets393,339
Total Liabilities317,573
Total Stockholder Equity75,766
 As reported
Total Liabilities 317,573
Total Stockholder Equity+ 75,766
Total Assets = 393,339

Assets

Total Assets393,339
Total Current Assets50,638
Long-term Assets50,638
Total Current Assets
Cash And Cash Equivalents 20,696
Net Receivables 14,690
Inventory 15,252
Total Current Assets  (as reported)50,638
Total Current Assets  (calculated)50,638
+/-0
Long-term Assets
Property Plant Equipment 8,366
Intangible Assets 312,779
Long-term Assets Other 502
Long-term Assets  (as reported)321,145
Long-term Assets  (calculated)321,647
+/- 502

Liabilities & Shareholders' Equity

Total Current Liabilities39,664
Long-term Liabilities277,909
Total Stockholder Equity75,766
Total Current Liabilities
Short-term Debt 1,454
Accounts payable 38,210
Other Current Liabilities 2,359
Total Current Liabilities  (as reported)39,664
Total Current Liabilities  (calculated)42,023
+/- 2,359
Long-term Liabilities
Long term Debt 187,689
Capital Lease Obligations Min Short Term Debt4,612
Other Liabilities 83,249
Long-term Liabilities Other 41,021
Long-term Liabilities  (as reported)277,909
Long-term Liabilities  (calculated)316,571
+/- 38,662
Total Stockholder Equity
Common Stock75,766
Total Stockholder Equity (as reported)75,766
Total Stockholder Equity (calculated)75,766
+/-0
Other
Cash and Short Term Investments 20,696
Common Stock Shares Outstanding 24,290
Liabilities and Stockholders Equity 393,339
Net Debt 148,130
Net Invested Capital 187,689
Net Tangible Assets -237,013
Net Working Capital 29,669
Short Long Term Debt Total 168,826



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-11-042013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302004-12-312003-12-312003-09-30
> Total Assets 
57,024
45,960
30,982
25,543
33,912
49,553
44,193
40,317
84,368
68,086
133,908
136,858
127,306
196,130
184,398
297,979
281,501
261,666
368,170
337,597
319,471
318,216
295,988
331,421
335,707,642
336,207
336,095
351,098
379,488
386,052
403,053
410,453
565,332
565,423
575,906
586,647
586,647
607,127
611,887
943,317
972,767
1,080,679
1,098,982
1,100,550
1,100,278
1,116,343
1,211,694
1,346,539
1,318,368
1,342,335
1,319,842
1,332,442
1,345,058
1,197,969
1,187,073
1,250,616
1,311,085
1,299,666
1,233,938
1,197,462
879,913
799,718
753,827
728,208
710,447
632,680
584,048
491,498
466,087
455,470
424,138
406,312
393,339
393,339406,312424,138455,470466,087491,498584,048632,680710,447728,208753,827799,718879,9131,197,4621,233,9381,299,6661,311,0851,250,6161,187,0731,197,9691,345,0581,332,4421,319,8421,342,3351,318,3681,346,5391,211,6941,116,3431,100,2781,100,5501,098,9821,080,679972,767943,317611,887607,127586,647586,647575,906565,423565,332410,453403,053386,052379,488351,098336,095336,207335,707,642331,421295,988318,216319,471337,597368,170261,666281,501297,979184,398196,130127,306136,858133,90868,08684,36840,31744,19349,55333,91225,54330,98245,96057,024
   > Total Current Assets 
53,912
0
0
17,392
25,464
41,440
36,344
32,878
72,233
55,988
117,053
120,103
111,034
175,261
164,202
278,410
262,048
242,140
341,493
311,320
293,280
285,993
263,780
299,513
311,168,647
305,680
305,853
334,373
360,942
347,714
327,237
292,829
333,063
390,875
412,905
387,803
387,803
367,333
363,419
693,129
843,889
409,138
423,836
427,633
429,568
451,317
544,281
263,164
237,952
272,657
248,152
255,609
303,415
441,698
428,188
494,552
546,595
528,107
417,904
358,370
314,337
201,113
168,285
158,022
151,814
221,335
189,719
112,943
97,069
81,184
80,455
76,522
50,638
50,63876,52280,45581,18497,069112,943189,719221,335151,814158,022168,285201,113314,337358,370417,904528,107546,595494,552428,188441,698303,415255,609248,152272,657237,952263,164544,281451,317429,568427,633423,836409,138843,889693,129363,419367,333387,803387,803412,905390,875333,063292,829327,237347,714360,942334,373305,853305,680311,168,647299,513263,780285,993293,280311,320341,493242,140262,048278,410164,202175,261111,034120,103117,05355,98872,23332,87836,34441,44025,46417,3920053,912
       Cash And Cash Equivalents 
8,033
8,965
11,729
3,581
11,761
25,961
23,684
11,921
18,101
13,173
35,474
20,626
16,810
67,435
34,253
79,785
29,613
36,118
32,697
25,708
47,314
85,732
75,669
82,405
34,640,716
78,457
48,635
44,385
57,954
55,300
64,717
40,026
41,876
34,687
42,702
46,266
46,266
48,037
44,355
274,599
53,341
182,170
61,515
76,197
89,837
153,204
431,414
137,400
127,940
158,537
133,619
141,135
192,496
307,068
226,276
243,345
321,011
293,564
197,093
147,648
119,521
62,085
32,417
40,577
57,910
71,369
116,773
45,714
36,168
45,634
31,873
23,127
20,696
20,69623,12731,87345,63436,16845,714116,77371,36957,91040,57732,41762,085119,521147,648197,093293,564321,011243,345226,276307,068192,496141,135133,619158,537127,940137,400431,414153,20489,83776,19761,515182,17053,341274,59944,35548,03746,26646,26642,70234,68741,87640,02664,71755,30057,95444,38548,63578,45734,640,71682,40575,66985,73247,31425,70832,69736,11829,61379,78534,25367,43516,81020,62635,47413,17318,10111,92123,68425,96111,7613,58111,7298,9658,033
       Short-term Investments 
43,836
32,505
9,653
5,160
2,001
3,990
500
6,440
35,656
32,014
69,207
84,507
78,310
92,858
114,757
183,460
216,435
189,834
179,697
266,706
224,778
157,856
140,770
163,412
205,388,685
146,890
179,565
224,428
237,953
222,945
191,133
192,204
191,949
248,659
260,627
246,043
246,043
225,891
226,065
331,254
713,100
125,448
238,182
225,523
233,593
200,101
190
0
0
79
61
0
68
410
106,767
148,371
139,935
151,989
146,157
149,242
133,636
63,754
50,477
25,410
5,347
0
0
0
0
0
0
0
0
000000005,34725,41050,47763,754133,636149,242146,157151,989139,935148,371106,767410680617900190200,101233,593225,523238,182125,448713,100331,254226,065225,891246,043246,043260,627248,659191,949192,204191,133222,945237,953224,428179,565146,890205,388,685163,412140,770157,856224,778266,706179,697189,834216,435183,460114,75792,85878,31084,50769,20732,01435,6566,4405003,9902,0015,1609,65332,50543,836
       Net Receivables 
164
0
0
820
744
784
1,420
3,946
9,389
2,373
3,638
3,806
4,266
4,120
4,957
4,017
4,622
4,603
115,331
4,246
5,739
7,944
17,926
18,229
22,271,697
23,795
23,416
20,608
22,828
21,526
23,607
23,227
26,327
23,288
27,055
24,998
50,098
30,784
29,265
27,027
24,792
32,211
30,551
29,797
31,755
31,466
41,623
45,886
48,575
52,239
50,238
55,626
53,825
81,403
50,787
64,360
51,461
23,430
20,652
21,010
17,553
22,083
14,969
14,773
13,385
20,193
17,295
14,010
13,587
17,002
11,990
14,270
14,690
14,69014,27011,99017,00213,58714,01017,29520,19313,38514,77314,96922,08317,55321,01020,65223,43051,46164,36050,78781,40353,82555,62650,23852,23948,57545,88641,62331,46631,75529,79730,55132,21124,79227,02729,26530,78450,09824,99827,05523,28826,32723,22723,60721,52622,82820,60823,41623,79522,271,69718,22917,9267,9445,7394,246115,3314,6034,6224,0174,9574,1204,2663,8063,6382,3739,3893,9461,42078474482000164
       Other Current Assets 
1,880
1,115
1,069
2,877
4,200
4,368
3,389
3,430
2,867
3,334
2,738
3,985
3,923
4,105
3,760
3,695
5,233
6,521
7,695
8,885
8,556
10,849
9,401
9,285
12,635,451
11,743
12,092
15,183
13,825
19,284
18,367
18,132
51,954
55,655
50,831
44,251
16,858
36,449
32,580
28,848
25,441
42,472
47,757
46,914
27,545
30,070
31,577
24,325
20,502
18,746
18,241
14,934
17,224
15,726
16,696
17,329
23,388
30,110
22,537
12,384
16,231
27,970
44,855
44,322
45,052
101,096
28,236
27,864
26,719
20,973
21,756
23,804
7,822
7,82223,80421,75620,97326,71927,86428,236101,09645,05244,32244,85527,97016,23112,38422,53730,11023,38817,32916,69615,72617,22414,93418,24118,74620,50224,32531,57730,07027,54546,91447,75742,47225,44128,84832,58036,44916,85844,25150,83155,65551,95418,13218,36719,28413,82515,18312,09211,74312,635,4519,2859,40110,8498,5568,8857,6956,5215,2333,6953,7604,1053,9233,9852,7383,3342,8673,4303,3894,3684,2002,8771,0691,1151,880
   > Long-term Assets 
3,112
0
0
8,151
8,448
8,113
7,849
7,439
12,135
12,098
16,855
16,755
16,273
20,868
20,197
19,569
19,453
19,525
26,677
26,277
26,190
32,223
32,207
31,908
24,538,995
30,527
30,242
16,725
18,546
38,338
75,816
117,624
232,269
174,548
163,001
198,844
239,794
239,794
248,468
250,188
128,878
671,541
675,146
672,917
670,710
665,026
667,413
1,083,375
1,080,416
1,069,678
1,071,690
1,076,833
1,041,643
756,271
758,885
756,064
764,490
771,559
816,034
839,092
565,576
598,605
585,542
570,186
558,633
411,345
394,329
378,555
369,018
347,113
343,683
329,790
321,145
321,145329,790343,683347,113369,018378,555394,329411,345558,633570,186585,542598,605565,576839,092816,034771,559764,490756,064758,885756,2711,041,6431,076,8331,071,6901,069,6781,080,4161,083,375667,413665,026670,710672,917675,146671,541128,878250,188248,468239,794239,794198,844163,001174,548232,269117,62475,81638,33818,54616,72530,24230,52724,538,99531,90832,20732,22326,19026,27726,67719,52519,45319,56920,19720,86816,27316,75516,85512,09812,1357,4397,8498,1138,4488,151003,112
       Property Plant Equipment 
3,001
3,093
2,547
1,905
1,707
1,577
1,482
1,277
1,223
1,420
1,427
1,741
1,652
1,867
1,826
1,869
2,348
2,780
3,044
3,344
1,891
2,087
2,788
3,321
3,203
3,594
3,543
3,595
3,858
6,521
14,290
16,437
16,706
16,936
17,740
17,752
16,525
16,525
16,440
15,823
17,089
46,090
45,919
44,453
42,415
40,204
38,027
36,754
35,777
34,310
37,132
37,368
36,484
36,669
39,023
42,524
52,061
60,519
83,032
113,455
130,585
142,527
142,500
141,685
139,255
25,744
16,464
14,664
12,877
11,133
9,255
8,815
8,366
8,3668,8159,25511,13312,87714,66416,46425,744139,255141,685142,500142,527130,585113,45583,03260,51952,06142,52439,02336,66936,48437,36837,13234,31035,77736,75438,02740,20442,41544,45345,91946,09017,08915,82316,44016,52516,52517,75217,74016,93616,70616,43714,2906,5213,8583,5953,5433,5943,2033,3212,7882,0871,8913,3443,0442,7802,3481,8691,8261,8671,6521,7411,4271,4201,2231,2771,4821,5771,7071,9052,5473,0933,001
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
182,952
182,952
182,952
183,636
183,636
183,636
284,504
284,029
280,599
278,069
281,896
285,317
286,611
289,577
284,100
283,435
282,059
280,128
281,467
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000281,467280,128282,059283,435284,100289,577286,611285,317281,896278,069280,599284,029284,504183,636183,636183,636182,952182,952182,95200000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,046
47,118
86,434
99,363
41,559
29,050
57,069
93,299
93,299
101,732
121,855
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000121,855101,73293,29993,29957,06929,05041,55999,36386,43447,11817,04600000000000000000000000000000
       Intangible Assets 
0
0
3,386
6,137
5,952
5,768
5,583
5,398
10,178
9,950
14,723
14,333
13,944
18,348
17,751
17,155
16,565
16,245
15,924
15,603
17,149
23,180
22,657
22,013
21,336,259
20,707
20,502
7,053
8,769
8,950
8,755
9,279
9,319
9,446
9,875
17,590
17,590
17,459
17,959
17,281
16,865
432,822
432,155
431,759
431,279
430,856
430,491
751,524
749,415
742,242
740,838
742,704
705,141
430,603
429,791
428,762
428,575
428,570
425,777
418,000
410,023
402,329
390,311
382,505
374,743
366,981
359,245
351,481
343,731
335,980
328,228
320,472
312,779
312,779320,472328,228335,980343,731351,481359,245366,981374,743382,505390,311402,329410,023418,000425,777428,570428,575428,762429,791430,603705,141742,704740,838742,242749,415751,524430,491430,856431,279431,759432,155432,82216,86517,28117,95917,45917,59017,5909,8759,4469,3199,2798,7558,9508,7697,05320,50220,70721,336,25922,01322,65723,18017,14915,60315,92416,24516,56517,15517,75118,34813,94414,33314,7239,95010,1785,3985,5835,7685,9526,1373,38600
       Long-term Assets Other 
112
0
0
109
789
768
784
764
734
728
705
681
677
654
619
545
539
501
7,709
7,330
7,150
6,956
6,762
6,574
3,199,533
6,226
6,197
6,077
5,919
5,821
5,653
5,474
5,245
5,062
4,883
4,708
352
4,526
4,352
10,344
10,039
9,677
14,120
13,753
13,380
8,202
2,986
8,465
8,244
8,127
11,251
10,465
10,301
2,388
494
678
419
411
27,097
26,170
24,968
53,749
52,731
45,996
44,635
18,620
18,620
363,891
356,141
6,200
334,428
503
502
502503334,4286,200356,141363,89118,62018,62044,63545,99652,73153,74924,96826,17027,0974114196784942,38810,30110,46511,2518,1278,2448,4652,9868,20213,38013,75314,1209,67710,03910,3444,3524,5263524,7084,8835,0625,2455,4745,6535,8215,9196,0776,1976,2263,199,5336,5746,7626,9567,1507,3307,70950153954561965467768170572873476478476878910900112
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,380
6,215
6,050
0
5,759
5,600
0
5,283
5,125
4,967
106,444
106,194
105,944
106,057
112,159
112,159
112,000
88,742
88,583
-20,345
3,381
3,223
3,064
5,034
15,020
4,717
2,430
2,272
2,113
1,955
1,796
1,638
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,6381,7961,9552,1132,2722,4304,71715,0205,0343,0643,2233,381-20,34588,58388,742112,000112,159112,159106,057105,944106,194106,4444,9675,1255,28305,6005,75906,0506,2156,3800000000000000000000000
> Total Liabilities 
39,541
15,919
25,189
127,212
150,448
49,835
46,391
48,711
65,699
54,497
63,227
61,840
63,874
69,428
71,986
73,634
74,343
70,174
196,374
181,320
182,138
194,769
173,289
189,059
342,101,444
181,419
173,343
164,182
174,279
166,958
173,403
164,986
179,411
173,784
171,108
160,256
586,647
166,774
161,367
442,938
449,854
540,424
549,962
540,266
525,390
513,318
527,682
664,997
651,602
678,124
643,715
642,722
665,068
677,982
637,148
643,981
712,460
687,683
667,352
652,625
598,571
488,898
447,153
437,303
396,916
394,725
377,769
301,017
301,612
304,333
296,589
318,405
317,573
317,573318,405296,589304,333301,612301,017377,769394,725396,916437,303447,153488,898598,571652,625667,352687,683712,460643,981637,148677,982665,068642,722643,715678,124651,602664,997527,682513,318525,390540,266549,962540,424449,854442,938161,367166,774586,647160,256171,108173,784179,411164,986173,403166,958174,279164,182173,343181,419342,101,444189,059173,289194,769182,138181,320196,37470,17474,34373,63471,98669,42863,87461,84063,22754,49765,69948,71146,39149,835150,448127,21225,18915,91939,541
   > Total Current Liabilities 
6,836
7,381
15,872
29,595
35,858
26,554
23,965
27,443
38,910
28,778
38,229
36,659
39,264
45,195
46,337
48,464
54,603
50,630
74,153
64,888
72,900
89,162
70,767
89,448
94,249,568
88,074
82,576
74,437
87,343
82,057
88,433
82,039
98,871
96,864
96,860
88,258
88,258
96,643
94,705
94,612
100,921
114,383
122,165
111,671
93,239
90,592
105,004
136,125
118,122
147,901
119,335
107,142
109,738
143,960
117,358
120,871
135,708
140,256
97,287
93,951
91,993
86,385
70,628
138,228
138,749
137,252
133,051
67,656
68,271
8,186
46,000
41,120
39,664
39,66441,12046,0008,18668,27167,656133,051137,252138,749138,22870,62886,38591,99393,95197,287140,256135,708120,871117,358143,960109,738107,142119,335147,901118,122136,125105,00490,59293,239111,671122,165114,383100,92194,61294,70596,64388,25888,25896,86096,86498,87182,03988,43382,05787,34374,43782,57688,07494,249,56889,44870,76789,16272,90064,88874,15350,63054,60348,46446,33745,19539,26436,65938,22928,77838,91027,44323,96526,55435,85829,59515,8727,3816,836
       Short-term Debt 
317
0
0
2,347
1,068
1,041
1,020
1,011
1,044
995
732
463
188
188
0
0
0
0
0
0
0
1,144
1,144
1,144
1,144
1,144
1,144
1,144
1,144
1,144
1,144
1,144
7,505
1,144
1,144
1,144
1,144
9,043
1,144
1,144
1,144
11,840
1,144
1,144
1,144
13,468
1,117
1,126
1,134
22,983
754
615
636
11,375
663
629
624
18,997
8,062
8,256
8,283
11,560
8,438
75,374
75,943
85,190
74,727
10,708
9,316
8,186
7,036
1,347
1,454
1,4541,3477,0368,1869,31610,70874,72785,19075,94375,3748,43811,5608,2838,2568,06218,99762462966311,37563661575422,9831,1341,1261,11713,4681,1441,1441,14411,8401,1441,1441,1449,0431,1441,1441,1441,1447,5051,1441,1441,1441,1441,1441,1441,1441,1441,1441,1441,14400000001881884637329951,0441,0111,0201,0411,0682,34700317
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,144
0
0
0
1,169
1,117
1,126
1,134
7,021
754
328,712
636
645
663
629
624
616
604
612
587
3,814
592
67,478
68,050
68,631
68,529
0
0
0
0
0
0
00000068,52968,63168,05067,4785923,814587612604616624629663645636328,7127547,0211,1341,1261,1171,1690001,14400000000000000000000000000000000000000000
       Accounts payable 
3,602
2,659
1,929
1,810
4,134
2,052
2,944
2,162
3,315
1,954
2,809
7,809
6,676
5,905
10,023
12,250
10,125
7,317
13,885
9,643
11,613
24,522
7,125
17,363
16,961,250
19,184
16,706
13,943
21,393
20,010
19,721
18,460
24,183
24,077
21,189
15,907
53,491
17,985
21,506
20,660
20,507
20,291
21,886
16,947
14,005
17,071
21,355
29,554
18,557
29,910
21,378
19,967
21,741
31,074
18,377
15,400
29,554
49,368
25,955
26,724
26,777
26,837
12,073
14,631
10,361
12,882
9,488
17,483
15,500
10,845
8,768
7,958
38,210
38,2107,9588,76810,84515,50017,4839,48812,88210,36114,63112,07326,83726,77726,72425,95549,36829,55415,40018,37731,07421,74119,96721,37829,91018,55729,55421,35517,07114,00516,94721,88620,29120,50720,66021,50617,98553,49115,90721,18924,07724,18318,46019,72120,01021,39313,94316,70619,18416,961,25017,3637,12524,52211,6139,64313,8857,31710,12512,25010,0235,9056,6767,8092,8091,9543,3152,1622,9442,0524,1341,8101,9292,6593,602
       Other Current Liabilities 
2,861
4,398
13,641
9,792
13,920
6,945
5,689
7,963
14,109
7,155
15,652
8,814
10,563
15,798
11,618
12,839
20,175
17,945
26,882
18,691
21,154
24,360
23,903
32,185
71,237,173
27,753
26,795
20,974
25,150
21,691
29,520
24,578
28,851
32,966
35,385
30,929
41,147
28,468
31,781
34,289
40,698
43,775
60,957
56,120
69,033
50,996
73,475
96,388
89,374
85,951
88,146
77,503
78,304
92,454
98,318
104,842
105,530
71,891
63,270
58,971
56,933
47,988
50,117
48,223
52,445
39,180
48,836
39,465
43,455
-10,845
30,196
31,815
2,359
2,35931,81530,196-10,84543,45539,46548,83639,18052,44548,22350,11747,98856,93358,97163,27071,891105,530104,84298,31892,45478,30477,50388,14685,95189,37496,38873,47550,99669,03356,12060,95743,77540,69834,28931,78128,46841,14730,92935,38532,96628,85124,57829,52021,69125,15020,97426,79527,75371,237,17332,18523,90324,36021,15418,69126,88217,94520,17512,83911,61815,79810,5638,81415,6527,15514,1097,9635,6896,94513,9209,79213,6414,3982,861
   > Long-term Liabilities 
8,525
0
0
97,617
114,590
23,282
22,427
21,268
26,790
25,719
24,999
25,181
24,610
24,232
25,649
25,170
19,740
19,544
122,221
116,432
109,238
105,607
102,522
99,611
40,171,870
93,345
90,767
89,745
86,936
84,901
84,970
82,947
80,540
76,920
74,248
71,998
69,984
70,131
66,662
348,326
348,933
426,041
427,797
428,595
432,151
422,726
422,678
528,872
533,480
530,223
524,380
535,580
555,330
534,022
519,790
523,110
576,752
547,427
570,065
558,674
506,578
402,513
376,525
299,075
258,167
257,473
244,718
233,361
233,341
296,147
250,589
277,285
277,909
277,909277,285250,589296,147233,341233,361244,718257,473258,167299,075376,525402,513506,578558,674570,065547,427576,752523,110519,790534,022555,330535,580524,380530,223533,480528,872422,678422,726432,151428,595427,797426,041348,933348,32666,66270,13169,98471,99874,24876,92080,54082,94784,97084,90186,93689,74590,76793,34540,171,87099,611102,522105,607109,238116,432122,22119,54419,74025,17025,64924,23224,61025,18124,99925,71926,79021,26822,42723,282114,59097,617008,525
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,061
10,507
9,772
8,419
8,122
7,801
7,128
6,034
5,702
5,452
5,355
4,024
3,918
3,855
3,721
3,721
2,455
286,341
287,998
289,883
290,665
292,612
294,583
296,576
292,624
294,854
297,111
324,030
326,366
328,097
331,585
334,475
337,128
338,377
340,833
343,140
345,853
349,017
350,899
218,269
220,062
157,288
161,600
166,174
168,374
172,327
0
0
0
0
0
00000172,327168,374166,174161,600157,288220,062218,269350,899349,017345,853343,140340,833338,377337,128334,475331,585328,097326,366324,030297,111294,854292,624296,576294,583292,612290,665289,883287,998286,3412,4553,7213,7213,8553,9184,0245,3555,4525,7026,0347,1287,8018,1228,4199,77210,50711,0610000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,380
6,215
6,050
0
5,759
5,600
0
5,283
5,125
4,967
106,444
106,194
105,944
106,057
112,159
112,159
112,000
88,742
88,583
-20,345
3,381
3,223
3,064
5,034
15,020
4,717
2,430
2,272
2,113
1,955
1,796
1,638
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,6381,7961,9552,1132,2722,4304,71715,0205,0343,0643,2233,381-20,34588,58388,742112,000112,159112,159106,057105,944106,194106,4444,9675,1255,28305,6005,75906,0506,2156,3800000000000000000000000
       Other Liabilities 
0
0
750
388
549
604
447
532
350
350
363
363
463
463
412
413
337
337
103,845
98,627
96,495
94,138
91,462
89,104
86,819
84,926
82,645
81,944
79,808
78,867
79,268
77,495
75,185
72,896
70,330
68,143
0
66,410
64,207
55,524
60,935
112,273
113,247
112,098
113,000
114,004
117,908
144,058
144,940
113,386
121,884
127,927
125,208
177,088
182,662
184,733
235,919
204,287
197,757
183,891
131,286
161,248
134,706
121,510
77,820
74,099
66,534
56,994
53,678
67,552
64,280
87,414
83,249
83,24987,41464,28067,55253,67856,99466,53474,09977,820121,510134,706161,248131,286183,891197,757204,287235,919184,733182,662177,088125,208127,927121,884113,386144,940144,058117,908114,004113,000112,098113,247112,27360,93555,52464,20766,410068,14370,33072,89675,18577,49579,26878,86779,80881,94482,64584,92686,81989,10491,46294,13896,49598,627103,84533733741341246346336336335035053244760454938875000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91,143
88,786
86,429
84,535
82,271
80,007
77,742
75,478
73,214
70,949
68,685
66,421
64,156
61,892
59,628
59,628
57,363
55,099
52,835
74,455
72,191
69,927
68,345
53,659
51,395
126,944
126,149
125,263
106,321
107,483
124,200
45,857
24,936
37,586
70,656
7,483
5,401
3,069
2,804
68,990
49,272
41,028
23,952
20,309
16,913
15,722
0
0
0
0
0
0000015,72216,91320,30923,95241,02849,27268,9902,8043,0695,4017,48370,65637,58624,93645,857124,200107,483106,321125,263126,149126,94451,39553,65968,34569,92772,19174,45552,83555,09957,36359,62859,62861,89264,15666,42168,68570,94973,21475,47877,74280,00782,27184,53586,42988,78691,1430000000000000000000000
> Total Stockholder Equity
17,484
30,041
5,793
-101,669
-116,536
-283
-2,199
-8,393
18,669
13,589
70,680
75,019
63,433
126,702
112,412
224,344
207,157
191,492
171,797
156,277
137,333
123,447
122,699
142,362
151,261
154,788
162,752
186,916
205,209
219,094
229,650
245,467
385,921
391,639
404,798
426,391
440,353
440,353
450,520
500,379
522,913
540,255
549,020
560,284
574,888
603,025
684,012
671,638
666,766
664,211
676,127
689,720
679,990
519,987
549,925
606,635
598,625
611,983
566,586
544,837
281,342
310,820
306,674
290,905
313,531
237,955
206,279
190,481
164,475
151,137
127,549
87,907
75,766
75,76687,907127,549151,137164,475190,481206,279237,955313,531290,905306,674310,820281,342544,837566,586611,983598,625606,635549,925519,987679,990689,720676,127664,211666,766671,638684,012603,025574,888560,284549,020540,255522,913500,379450,520440,353440,353426,391404,798391,639385,921245,467229,650219,094205,209186,916162,752154,788151,261142,362122,699123,447137,333156,277171,797191,492207,157224,344112,412126,70263,43375,01970,68013,58918,669-8,393-2,199-283-116,536-101,6695,79330,04117,484
   Common Stock
0
0
0
0
0
20
20
20
24
24
27
28
29
32
33
38
38
38
38
38
38
38
38
39
38,779
39
39
39
39
39
39
39
40
40
40
41
41
41
41
41
41
42
43
43
43
43
46
46
46
46
47
47
47
46
47
47
47
48
48
48
48
48
48
48
48
9
9
11
11
13
13
24
75,766
75,7662413131111994848484848484848474747464747474646464643434343424141414141414040403939393939393938,7793938383838383838383332292827242420202000000
   Retained Earnings 0-941,561-894,879-870,357-849,789-822,718-799,855-766,403-683,355-690,702-673,281-666,809-732,469-468,934-441,448-393,843-403,439-389,527-435,725-455,108-284,148-258,953-250,757-243,970-240,876-228,152-209,872-209,352-218,557-222,498-223,495-220,410-220,741-232,694-237,379-238,082-238,082-244,274-251,751-255,662-254,523-387,496-397,090-401,635-409,481-422,175-441,043-440,758-440,086-443,757-456,194-449,431-428,317-405,843-386,413-363,085-344,376-324,145-305,289-286,467-270,036-256,306-247,774-239,610-232,061-225,052-217,882-214,986-208,042-198,47500-114,283
   Accumulated Other Comprehensive Income 
-1,378
0
0
-6
-2
-2
-3
6
13
10
97
227
296
576
124
852
813
185
124
236
109
44
9
22
-13
40
112
69
66
-34
-39
69
62
83
54
98
98
37
82
96
166
-74
-91
-60
-43
-119
0
-4,711
-3,615
-12,901
-10,499
-329
6,937
6,858
9,313
4,799
4,113
2,806
1,375
2,617
-636
-1,169
-819
-1,223
-2,286
-2,803
-1,734
-1,833
-1,557
-1,017
-568
738
0
0738-568-1,017-1,557-1,833-1,734-2,803-2,286-1,223-819-1,169-6362,6171,3752,8064,1134,7999,3136,8586,937-329-10,499-12,901-3,615-4,7110-119-43-60-91-74166968237989854836269-39-34666911240-13229441092361241858138521245762962279710136-3-2-2-600-1,378
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
578,845
586,058
591,649
595,796
603,973
609,312
614,914
621,053
627,069
633,184
640,671
647,507
656,784
670,855
678,686
678,686
688,105
733,265
743,776
761,026
772,892
783,128
793,774
812,782
894,167
904,784
911,540
921,365
937,665
949,344
957,543
968,580
977,881
993,292
999,880
1,005,105
1,008,796
1,011,744
1,015,037
979,388
981,364
983,420
999,762
1,007,790
1,008,497
1,015,659
0
0
0
0
0
000001,015,6591,008,4971,007,790999,762983,420981,364979,3881,015,0371,011,7441,008,7961,005,105999,880993,292977,881968,580957,543949,344937,665921,365911,540904,784894,167812,782793,774783,128772,892761,026743,776733,265688,105678,686678,686670,855656,784647,507640,671633,184627,069621,053614,914609,312603,973595,796591,649586,058578,8450000000000000000000000
   Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-329
329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-329
-389
-389
-389
-1,591
-1,976
-1,976
-2,133
-2,185
-638
-638
-638
-638
-638
-638
-638
-638
-638
0
0
0
0
0
00000-638-638-638-638-638-638-638-638-638-2,185-2,133-1,976-1,976-1,591-389-389-389-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329-329329-329000000000000000000000000
   Other Stockholders Equity 
133,144
0
0
96,806
91,501
214,686
215,667
216,632
250,693
253,165
318,330
331,069
333,144
412,560
417,544
547,600
550,683
554,353
558,048
561,846
565,503
572,796
578,845
586,058
112,494
595,467
603,644
608,983
614,585
620,724
626,740
632,855
640,342
647,178
656,455
670,526
37
678,357
687,776
732,936
743,447
760,697
772,563
782,799
793,445
812,453
893,838
904,455
911,211
921,036
937,336
948,955
957,154
968,191
976,290
991,316
997,904
1,002,972
1,006,611
1,011,106
1,014,399
978,750
980,726
982,782
999,124
1,007,152
1,007,859
1,015,021
1,015,810
1,022,498
1,022,983
1,028,706
75,766
75,7661,028,7061,022,9831,022,4981,015,8101,015,0211,007,8591,007,152999,124982,782980,726978,7501,014,3991,011,1061,006,6111,002,972997,904991,316976,290968,191957,154948,955937,336921,036911,211904,455893,838812,453793,445782,799772,563760,697743,447732,936687,776678,35737670,526656,455647,178640,342632,855626,740620,724614,585608,983603,644595,467112,494586,058578,845572,796565,503561,846558,048554,353550,683547,600417,544412,560333,144331,069318,330253,165250,693216,632215,667214,68691,50196,80600133,144



Balance Sheet

Currency in USD. All numbers in thousands.